Table 3.

Cox univariate and multivariate analyses of survival according to neutrophil‐to‐lymphocyte ratio (NLR) in patients without postoperative adjuvant hormone therapy or radiotherapy

	BCR‐free time		Overall survival time
	HR (95%CI)	P‐value	HR (95%CI)	P‐value
Univariate analysis
NLR		0.019		0.075
<2	1		1
≥2	0.680 (0.493‐0.938)		2.068 (0.929‐4.606)
Multivariate analysis
NLR		0.007		0.395
<2	1.000		1.000
≥2	0.600 (0.413‐0.871)		1.466 (0.607‐3.542)
pT stage		0.002		0.176
Low (pT2)	1		1
High (pT3‐4)	1.794 (1.230‐2.616)		0.452 (0.143‐1.427)
pN stage		0.698		0.550
Negative	1		1
Positive	1.171 (0.528 ‐2.595)		1.900 (0.232‐15.556)
Gleason grade		<0.001		0.114
Low (<4 + 4)	1		1
High (≥4 + 4)	3.317 (2.294‐4.797)		2.184 (0.830‐5.750)
PSA level		0.098		0.376
Low (≤10 ng/mL)	1.000		1.000
High (>10 ng/mL)	1.425 (0.937‐2.166)		1.552 (0.587‐4.106)

PSA, prostate specific antigen.